Savara Inc.
Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Its mission is to develop and commercialize novel, best-in-class medicines to address unmet medical needs in rare respiratory conditions, particularly autoimmune pulmonary alveolar proteinosis (aPAP). The company is advancing its lead product candidate, molgramostim, in Phase 3 development, and is dedicated to improving treatment options for patients with these rare diseases.
Industries
Nr. of Employees
small (1-50)
Savara Inc.
One Summit Square, 1717 Langhorne Newtown Road, Suite 300, Langhorne, PA 19047
Products
Molgramostim inhalation solution (investigational)
Non-glycosylated recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) formulated for inhalation and developed as a potential treatment for autoimmune pulmonary alveolar proteinosis; in late-stage clinical development.
Molgramostim inhalation solution (investigational)
Non-glycosylated recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) formulated for inhalation and developed as a potential treatment for autoimmune pulmonary alveolar proteinosis; in late-stage clinical development.
Services
Global early access policy and program (case-by-case review) to provide investigational product to eligible patients outside of clinical trials, administered in partnership with a specialist expanded access provider.
Provision of medical information resources, support for investigator-sponsored trials, congress participation, and publication planning to disseminate clinical and scientific data.
Global early access policy and program (case-by-case review) to provide investigational product to eligible patients outside of clinical trials, administered in partnership with a specialist expanded access provider.
Provision of medical information resources, support for investigator-sponsored trials, congress participation, and publication planning to disseminate clinical and scientific data.
Expertise Areas
- Clinical trial management
- Inhaled biologic development
- Rare respiratory disease therapeutics
- cGMP biologics manufacturing and scale-up
Key Technologies
- Inhalation drug delivery
- Recombinant protein biologics
- cGMP manufacturing
- Technology transfer and scale-up
News & Updates
Explore recent scientific publications related to Savara's research and development efforts.
Explore recent scientific publications related to Savara's research and development efforts.